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Introduction
• Asthma is a chronic respiratory 
disorder that affects over 300 million 
people worldwide. 
• This disorder is characterized by airway 
hyper-responsiveness and 
inflammation.
• Asthma is seen in patients across the 
lifespan. 
• Asthma continues to increase in 
prevalence and is one of the most 
common lung disorders seen and 
treated in the healthcare setting 
(Fehrenbach, Wagner, and Wegmann
2017, p 551). 
• The original presentation or development 
of asthma may occur in children or adults
• Acute asthma exacerbation may be 
gradual or sudden in onset, depending on 
the phenotype (Restrepo, et al, p 534).
• be seen in pediatric patients, or it may 
have a new onset in adulthood. 
• Effective management is multi-factorial
• This topic was chosen due to it’s relevance 
in the healthcare setting, and applicability 
to the practice of the APN. 
• APN’s must understand and be prepared 
to encounter this common illness.
Significance of Pathophysiology
• Asthma is thought to have two phenotypes; gradual onset and sudden onset. 
Depending on the phenotype, the response to interventions may be different. For 
example, in gradual onset there is mucus plugging in the airway, and a slower 
response to treatment. Sudden onset typically does not have mucus plugging, and 
responds more rapidly to treatment (Restrepo, et al, p 522). This is one example of 
why understanding the complex pathophysiological processes is crucial when 
diagnosing and treating patients. 
• Understanding the pathophysiology of asthma supports the ability to prevent acute 
attacks by avoiding triggers, or intervening early when symptoms begin.
• Early recognition and treatment of acute asthma exacerbation has direct effect on 
morbidity and mortality in these patients. 
• Understanding of the physiologic process occurring in asthmatic patients is critical in 
order to understand how therapeutic interventions impact the patient’s disease 
process.
Pathophysiology
• Asthma is characterized by two 
interrelated abnormalities: airway 
inflammation and airway hyper-
responsiveness. This disease is 
heterogeneous and chronic, with 
acute exacerbations (Donahue and 
Jain 2013, p 944).  
• Triggers for the airway inflammation 
and hyper-responsiveness that 
occurs with asthma include; exercise 
and numerous exogenous factors 
such as aeroallergens, infections, 
cigarette smoke and other irritants. 
• Airway inflammation results from 
the activation of mast cells and 
antigen-specific Th2 cells, resulting in 
the production of cytokines, 
including interleukin (IL)-4, IL-5 and 
IL-13 (Donahue and Jain 2013, p 
945).  
• During an acute asthma exacerbation 
or, “attack”, a trigger is encountered 
and causes the airways to restrict 
and become narrow leading to 
hypoxia, hypercapnia, and acidosis. 
• Airway occlusion results from 
smooth muscle bronchoconstriction, 
airway edema and inflammation.  In 
addition to less air passing in and out 
of the lungs, excess mucus 
accumulates in the airway further 
impeding proper gas exchange 
(Dhankani, Girase, Chavan, & Pawar
S. 2013, p 413).
• Causes of asthma are multifactorial 
and are influenced by both 
environmental and genetic causes. 
• Allergic inflammation is well known 
to be a causative factor contributing 
to this disease. Asthma is influenced 
by inflammatory molecules such as 
Interleukin 6 (IL-6) (Nakajima et al 
2017, p 125).
• The Johns Hopkins Asthma and 
Allergy Center conducted a study 
that found that between 85 and 95% 
of patients with asthma had allergic 
rhinitis (Khan 2014, p 358). 
• Genetics play a distinct role in the 
patient’s susceptibility to developing 
asthma (Melen and Pershagen 2012, 
p 117). 
• Asthma is thought to be influenced 
by alterations in the microbiome of 
the lungs. Further research regarding 
the microbiota in asthmatic patients 
may lead to exciting new 
developments in asthma 
interventions (Sullivan et al. 2016, p 
1). 
Signs and Symptoms of Acute Asthma 
Exacerbation 







• Any combination of these 
symptoms 
• Evaluation of peak flow may be 
useful during asthma 
exacerbation, but only if 
patient’s individualized peak 
flow baseline is current and 
known during the time of 
treatment (Fanta 2017, p 1).
• An asthma exacerbation can usually 
be presented in the clinical setting 
under one of two subcategories; 
severe, or respiratory arrest 
imminent.
• Severe: characterized by dyspnea at 
rest that interferes with 
conversation, peak expiratory flow 
rate (PEFR) <40% predicted, usually 
requires emergency department (ED) 
visit and likely hospitalization. 
Patient experiences partial relief 
from frequent inhaled short-acting 
beta-agonists 
• Respiratory Arrest Imminent: Patient 
is too dyspneic to speak; sweating, 
PEFR <25% predicted, requires 
ED/hospitalization; possible ICU, 
minimal or no relief from frequent 
inhaler, intravenous corticosteroids, 
and/or adjunctive therapies.
Red flags of impending respiratory failure:
• Tachypnea 
• Tachycardia
• Use of accessory muscles 
• The presence of pulsus 
paradoxus in patients with 
acute severe asthma is an 
indication of ventilatory muscle 
fatigue and impending 
respiratory failure (Restrepo, et 
al, p 523).
• Use of mechanical ventilation is 
indicated when other therapies 
fail to improve the patient’s 
symptoms and the patient has 
had a decrease in respiratory 
effort, change in mental status, 
or exhibits hypercapnia and 
respiratory acidosis (Fanta 
2017, p 6).
Nursing Implications
• Presence of strong assessment skills in order to recognize this 
condition and intervene appropriately. Ability to identify 
abnormal lung sounds and recognize respiratory difficulty or 
distress.
• Facilitate communication with interdisciplinary care team as 
needed (i.e. Respiratory therapy). Other disciplines, such as 
radiology or laboratory, may be involved as well depending on 
presentation of the patient and physician’s orders.
Be knowledgeable regarding potential therapeutic interventions:
• Positioning patient 
• Use of oxygen and oxygen delivery methods
• Use of nebulizer, inhaler and spacer device.
• Oxygen titrated to maintain SpO2 of >92%. 
• Selective beta 2 agonists Antimuscarinics
• Corticosteroids
• Magnesium sulfate when indicated (Hazeldine 2013, p 48). 
• The nurse should be knowledgeable regarding potential side 
effects or adverse effects of the administered medications, 
such as tachycardia in response to inhaled albuterol. 
Educating patients on the following:
• Risk factors
• Avoidance of triggers
• Proper use of rescue inhaler
• Spacer use
• Asthma action plan
• Smoking cessation and/or second hand smoke avoidance
• When to seek emergency medical care during an acute attack
• Understanding of peak flow meter use and interpretation
• In severe cases, the nurse must be prepared for, and 
understand their role in, either non-invasive ventilation or 
invasive ventilation (intubation) of the patient.
• The patient should be kept NPO during the acute phase in 
order to prevent potential aspiration in the event of 
endotracheal intubation.
Conclusion
• Thorough and effective patient education is a key factor in 
preventing an acute exacerbation of asthma.
• Early intervention for patients experiencing acute asthma 
exacerbation is critical for positive outcomes. 
• With proper management and evidence based practice, mortality 
for patient’s with mild to moderate acute asthma exacerbation is 
low.
• However, approximately 10 to 30% of patients may still require 
positive pressure ventilation for severe acute asthma and mortality 
could be as high as 22% (Restrepo, et al, p532).
• Recognizing the signs and symptoms quickly will assist the APN in 
initiating the appropriate treatments in a timely manner. 
• Although Asthma has the ability to produce severe acute 
exacerbations that may become life threatening, this chronic illness 
can be properly managed with proper trigger/allergen 
identification, maintenance medications, asthma action plan, and 
periodic monitoring of the patient’s respiratory status using peak 
flow. 
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